Global and United States Human Herpersvirus 5 (HHV-5) Drug Market Report & Forecast 2024-2031

Report ID: 1842051 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Human Herpersvirus 5 (HHV-5) Drug Product Introduction
    1.2 Global Human Herpersvirus 5 (HHV-5) Drug Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume for the Year 2017-2028
    1.3 United States Human Herpersvirus 5 (HHV-5) Drug Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Human Herpersvirus 5 (HHV-5) Drug Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Human Herpersvirus 5 (HHV-5) Drug Sales in Volume for the Year 2017-2028
    1.4 Human Herpersvirus 5 (HHV-5) Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Human Herpersvirus 5 (HHV-5) Drug in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Human Herpersvirus 5 (HHV-5) Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Human Herpersvirus 5 (HHV-5) Drug Market Dynamics
        1.5.1 Human Herpersvirus 5 (HHV-5) Drug Industry Trends
        1.5.2 Human Herpersvirus 5 (HHV-5) Drug Market Drivers
        1.5.3 Human Herpersvirus 5 (HHV-5) Drug Market Challenges
        1.5.4 Human Herpersvirus 5 (HHV-5) Drug Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Human Herpersvirus 5 (HHV-5) Drug Market Segment by Type
        2.1.1 Ganciclovir
        2.1.2 Valerian Gilivir Drugs
        2.1.3 Acyclovir Drugs
        2.1.4 Valacyclovir Drugs
        2.1.5 Foscarnet Sodium Drugs
    2.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
        2.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Human Herpersvirus 5 (HHV-5) Drug Market Size by Type
        2.3.1 United States Human Herpersvirus 5 (HHV-5) Drug Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Human Herpersvirus 5 (HHV-5) Drug Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Human Herpersvirus 5 (HHV-5) Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Human Herpersvirus 5 (HHV-5) Drug Market Segment by Application
        3.1.1 Immunodeficiency Crowd
        3.1.2 Organ Transplant Crowd
        3.1.3 CMV Herpes Crowd
    3.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
        3.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Human Herpersvirus 5 (HHV-5) Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Human Herpersvirus 5 (HHV-5) Drug Market Size by Application
        3.3.1 United States Human Herpersvirus 5 (HHV-5) Drug Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Human Herpersvirus 5 (HHV-5) Drug Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Human Herpersvirus 5 (HHV-5) Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Human Herpersvirus 5 (HHV-5) Drug Competitor Landscape by Company
    4.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Company
        4.1.1 Top Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturer (2017-2022)
        4.1.3 Global Human Herpersvirus 5 (HHV-5) Drug Sales by Manufacturer (2017-2022)
        4.1.4 Global Human Herpersvirus 5 (HHV-5) Drug Price by Manufacturer (2017-2022)
    4.2 Global Human Herpersvirus 5 (HHV-5) Drug Concentration Ratio (CR)
        4.2.1 Human Herpersvirus 5 (HHV-5) Drug Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Herpersvirus 5 (HHV-5) Drug in 2021
        4.2.3 Global Human Herpersvirus 5 (HHV-5) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Human Herpersvirus 5 (HHV-5) Drug Manufacturing Base Distribution, Product Type
        4.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Human Herpersvirus 5 (HHV-5) Drug Product Type
        4.3.3 Date of International Manufacturers Enter into Human Herpersvirus 5 (HHV-5) Drug Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Human Herpersvirus 5 (HHV-5) Drug Market Size by Company
        4.5.1 Top Human Herpersvirus 5 (HHV-5) Drug Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Human Herpersvirus 5 (HHV-5) Drug Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Human Herpersvirus 5 (HHV-5) Drug Sales by Players (2020, 2021 & 2022)
5 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Region
    5.1 Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Human Herpersvirus 5 (HHV-5) Drug Market Size in Volume by Region (2017-2028)
        5.2.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Region: 2017-2022
        5.2.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Human Herpersvirus 5 (HHV-5) Drug Market Size in Value by Region (2017-2028)
        5.3.1 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Region: 2017-2022
        5.3.2 Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Human Herpersvirus 5 (HHV-5) Drug Market Size YoY Growth 2017-2028
        6.1.2 North America Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Human Herpersvirus 5 (HHV-5) Drug Market Size YoY Growth 2017-2028
        6.3.2 Europe Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Human Herpersvirus 5 (HHV-5) Drug Market Size YoY Growth 2017-2028
        6.4.2 Latin America Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Roche
        7.1.1 Roche Corporation Information
        7.1.2 Roche Description and Business Overview
        7.1.3 Roche Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Roche Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.1.5 Roche Recent Development
    7.2 Livzon Pharmaceuticals
        7.2.1 Livzon Pharmaceuticals Corporation Information
        7.2.2 Livzon Pharmaceuticals Description and Business Overview
        7.2.3 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.2.5 Livzon Pharmaceuticals Recent Development
    7.3 Sichuan Cologne Pharmaceutical
        7.3.1 Sichuan Cologne Pharmaceutical Corporation Information
        7.3.2 Sichuan Cologne Pharmaceutical Description and Business Overview
        7.3.3 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.3.5 Sichuan Cologne Pharmaceutical Recent Development
    7.4 Hubei Branch benefits medicine
        7.4.1 Hubei Branch benefits medicine Corporation Information
        7.4.2 Hubei Branch benefits medicine Description and Business Overview
        7.4.3 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.4.5 Hubei Branch benefits medicine Recent Development
    7.5 GlaxoSmithKline
        7.5.1 GlaxoSmithKline Corporation Information
        7.5.2 GlaxoSmithKline Description and Business Overview
        7.5.3 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.5.5 GlaxoSmithKline Recent Development
    7.6 Upright and clear
        7.6.1 Upright and clear Corporation Information
        7.6.2 Upright and clear Description and Business Overview
        7.6.3 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Upright and clear Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.6.5 Upright and clear Recent Development
    7.7 Chongqing Winbond (acquisition of Sichuan Mingxin)
        7.7.1 Chongqing Winbond (acquisition of Sichuan Mingxin) Corporation Information
        7.7.2 Chongqing Winbond (acquisition of Sichuan Mingxin) Description and Business Overview
        7.7.3 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.7.5 Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development
    7.8 Haikou Kellett
        7.8.1 Haikou Kellett Corporation Information
        7.8.2 Haikou Kellett Description and Business Overview
        7.8.3 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.8.5 Haikou Kellett Recent Development
    7.9 On the drug new Asia
        7.9.1 On the drug new Asia Corporation Information
        7.9.2 On the drug new Asia Description and Business Overview
        7.9.3 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.9.5 On the drug new Asia Recent Development
    7.10 Chongqing Fu'an Pharmaceutical
        7.10.1 Chongqing Fu'an Pharmaceutical Corporation Information
        7.10.2 Chongqing Fu'an Pharmaceutical Description and Business Overview
        7.10.3 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.10.5 Chongqing Fu'an Pharmaceutical Recent Development
    7.11 Shandong Luo Xin Pharmaceutical
        7.11.1 Shandong Luo Xin Pharmaceutical Corporation Information
        7.11.2 Shandong Luo Xin Pharmaceutical Description and Business Overview
        7.11.3 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Products Offered
        7.11.5 Shandong Luo Xin Pharmaceutical Recent Development
    7.12 Yangtze River Pharmaceutical
        7.12.1 Yangtze River Pharmaceutical Corporation Information
        7.12.2 Yangtze River Pharmaceutical Description and Business Overview
        7.12.3 Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Yangtze River Pharmaceutical Products Offered
        7.12.5 Yangtze River Pharmaceutical Recent Development
    7.13 Qianjiang Pharmaceuticals
        7.13.1 Qianjiang Pharmaceuticals Corporation Information
        7.13.2 Qianjiang Pharmaceuticals Description and Business Overview
        7.13.3 Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Qianjiang Pharmaceuticals Products Offered
        7.13.5 Qianjiang Pharmaceuticals Recent Development
    7.14 Wuhan Hualong
        7.14.1 Wuhan Hualong Corporation Information
        7.14.2 Wuhan Hualong Description and Business Overview
        7.14.3 Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Wuhan Hualong Products Offered
        7.14.5 Wuhan Hualong Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Human Herpersvirus 5 (HHV-5) Drug Industry Chain Analysis
    8.2 Human Herpersvirus 5 (HHV-5) Drug Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Human Herpersvirus 5 (HHV-5) Drug Distributors
    8.3 Human Herpersvirus 5 (HHV-5) Drug Production Mode & Process
    8.4 Human Herpersvirus 5 (HHV-5) Drug Sales and Marketing
        8.4.1 Human Herpersvirus 5 (HHV-5) Drug Sales Channels
        8.4.2 Human Herpersvirus 5 (HHV-5) Drug Distributors
    8.5 Human Herpersvirus 5 (HHV-5) Drug Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Human Herpersvirus 5 (HHV-5) Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Human Herpersvirus 5 (HHV-5) Drug Market Trends
    Table 3. Human Herpersvirus 5 (HHV-5) Drug Market Drivers
    Table 4. Human Herpersvirus 5 (HHV-5) Drug Market Challenges
    Table 5. Human Herpersvirus 5 (HHV-5) Drug Market Restraints
    Table 6. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Human Herpersvirus 5 (HHV-5) Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Human Herpersvirus 5 (HHV-5) Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Human Herpersvirus 5 (HHV-5) Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Human Herpersvirus 5 (HHV-5) Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Human Herpersvirus 5 (HHV-5) Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Human Herpersvirus 5 (HHV-5) Drug Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Human Herpersvirus 5 (HHV-5) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Human Herpersvirus 5 (HHV-5) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Herpersvirus 5 (HHV-5) Drug as of 2021)
    Table 18. Top Players of Human Herpersvirus 5 (HHV-5) Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Human Herpersvirus 5 (HHV-5) Drug Product Type
    Table 20. Date of International Manufacturers Enter into Human Herpersvirus 5 (HHV-5) Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Human Herpersvirus 5 (HHV-5) Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Human Herpersvirus 5 (HHV-5) Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Human Herpersvirus 5 (HHV-5) Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Human Herpersvirus 5 (HHV-5) Drug Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Human Herpersvirus 5 (HHV-5) Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Human Herpersvirus 5 (HHV-5) Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Human Herpersvirus 5 (HHV-5) Drug Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Roche Corporation Information
    Table 43. Roche Description and Business Overview
    Table 44. Roche Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Roche Human Herpersvirus 5 (HHV-5) Drug Product
    Table 46. Roche Recent Development
    Table 47. Livzon Pharmaceuticals Corporation Information
    Table 48. Livzon Pharmaceuticals Description and Business Overview
    Table 49. Livzon Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Livzon Pharmaceuticals Product
    Table 51. Livzon Pharmaceuticals Recent Development
    Table 52. Sichuan Cologne Pharmaceutical Corporation Information
    Table 53. Sichuan Cologne Pharmaceutical Description and Business Overview
    Table 54. Sichuan Cologne Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Sichuan Cologne Pharmaceutical Product
    Table 56. Sichuan Cologne Pharmaceutical Recent Development
    Table 57. Hubei Branch benefits medicine Corporation Information
    Table 58. Hubei Branch benefits medicine Description and Business Overview
    Table 59. Hubei Branch benefits medicine Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Hubei Branch benefits medicine Product
    Table 61. Hubei Branch benefits medicine Recent Development
    Table 62. GlaxoSmithKline Corporation Information
    Table 63. GlaxoSmithKline Description and Business Overview
    Table 64. GlaxoSmithKline Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. GlaxoSmithKline Product
    Table 66. GlaxoSmithKline Recent Development
    Table 67. Upright and clear Corporation Information
    Table 68. Upright and clear Description and Business Overview
    Table 69. Upright and clear Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Upright and clear Product
    Table 71. Upright and clear Recent Development
    Table 72. Chongqing Winbond (acquisition of Sichuan Mingxin) Corporation Information
    Table 73. Chongqing Winbond (acquisition of Sichuan Mingxin) Description and Business Overview
    Table 74. Chongqing Winbond (acquisition of Sichuan Mingxin) Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Chongqing Winbond (acquisition of Sichuan Mingxin) Product
    Table 76. Chongqing Winbond (acquisition of Sichuan Mingxin) Recent Development
    Table 77. Haikou Kellett Corporation Information
    Table 78. Haikou Kellett Description and Business Overview
    Table 79. Haikou Kellett Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Haikou Kellett Product
    Table 81. Haikou Kellett Recent Development
    Table 82. On the drug new Asia Corporation Information
    Table 83. On the drug new Asia Description and Business Overview
    Table 84. On the drug new Asia Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. On the drug new Asia Product
    Table 86. On the drug new Asia Recent Development
    Table 87. Chongqing Fu'an Pharmaceutical Corporation Information
    Table 88. Chongqing Fu'an Pharmaceutical Description and Business Overview
    Table 89. Chongqing Fu'an Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Chongqing Fu'an Pharmaceutical Product
    Table 91. Chongqing Fu'an Pharmaceutical Recent Development
    Table 92. Shandong Luo Xin Pharmaceutical Corporation Information
    Table 93. Shandong Luo Xin Pharmaceutical Description and Business Overview
    Table 94. Shandong Luo Xin Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Shandong Luo Xin Pharmaceutical Product
    Table 96. Shandong Luo Xin Pharmaceutical Recent Development
    Table 97. Yangtze River Pharmaceutical Corporation Information
    Table 98. Yangtze River Pharmaceutical Description and Business Overview
    Table 99. Yangtze River Pharmaceutical Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Yangtze River Pharmaceutical Product
    Table 101. Yangtze River Pharmaceutical Recent Development
    Table 102. Qianjiang Pharmaceuticals Corporation Information
    Table 103. Qianjiang Pharmaceuticals Description and Business Overview
    Table 104. Qianjiang Pharmaceuticals Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Qianjiang Pharmaceuticals Product
    Table 106. Qianjiang Pharmaceuticals Recent Development
    Table 107. Wuhan Hualong Corporation Information
    Table 108. Wuhan Hualong Description and Business Overview
    Table 109. Wuhan Hualong Human Herpersvirus 5 (HHV-5) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Wuhan Hualong Product
    Table 111. Wuhan Hualong Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Human Herpersvirus 5 (HHV-5) Drug Customers List
    Table 115. Human Herpersvirus 5 (HHV-5) Drug Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Herpersvirus 5 (HHV-5) Drug Product Picture
    Figure 2. Global Human Herpersvirus 5 (HHV-5) Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Human Herpersvirus 5 (HHV-5) Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Human Herpersvirus 5 (HHV-5) Drug Sales 2017-2028 (K Units)
    Figure 5. United States Human Herpersvirus 5 (HHV-5) Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Human Herpersvirus 5 (HHV-5) Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Human Herpersvirus 5 (HHV-5) Drug Sales 2017-2028 (K Units)
    Figure 8. United States Human Herpersvirus 5 (HHV-5) Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Human Herpersvirus 5 (HHV-5) Drug Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Human Herpersvirus 5 (HHV-5) Drug Report Years Considered
    Figure 11. Product Picture of Ganciclovir
    Figure 12. Product Picture of Valerian Gilivir Drugs
    Figure 13. Product Picture of Acyclovir Drugs
    Figure 14. Product Picture of Valacyclovir Drugs
    Figure 15. Product Picture of Foscarnet Sodium Drugs
    Figure 16. Global Human Herpersvirus 5 (HHV-5) Drug Market Share by Type in 2022 & 2028
    Figure 17. Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Human Herpersvirus 5 (HHV-5) Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 22. United States Human Herpersvirus 5 (HHV-5) Drug Market Share by Type in 2022 & 2028
    Figure 23. United States Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Human Herpersvirus 5 (HHV-5) Drug Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Human Herpersvirus 5 (HHV-5) Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 28. Product Picture of Immunodeficiency Crowd
    Figure 29. Product Picture of Organ Transplant Crowd
    Figure 30. Product Picture of CMV Herpes Crowd
    Figure 31. Global Human Herpersvirus 5 (HHV-5) Drug Market Share by Application in 2022 & 2028
    Figure 32. Global Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Human Herpersvirus 5 (HHV-5) Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 37. United States Human Herpersvirus 5 (HHV-5) Drug Market Share by Application in 2022 & 2028
    Figure 38. United States Human Herpersvirus 5 (HHV-5) Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Human Herpersvirus 5 (HHV-5) Drug Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Human Herpersvirus 5 (HHV-5) Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Human Herpersvirus 5 (HHV-5) Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 43. North America Human Herpersvirus 5 (HHV-5) Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Human Herpersvirus 5 (HHV-5) Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Human Herpersvirus 5 (HHV-5) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Human Herpersvirus 5 (HHV-5) Drug Value Chain
    Figure 77. Human Herpersvirus 5 (HHV-5) Drug Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Livzon Pharmaceuticals
Sichuan Cologne Pharmaceutical
Hubei Branch benefits medicine
GlaxoSmithKline
Upright and clear
Chongqing Winbond (acquisition of Sichuan Mingxin)
Haikou Kellett
On the drug new Asia
Chongqing Fu'an Pharmaceutical
Shandong Luo Xin Pharmaceutical
Yangtze River Pharmaceutical
Qianjiang Pharmaceuticals
Wuhan Hualong
Frequently Asked Questions
Human Herpersvirus 5 (HHV-5) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Herpersvirus 5 (HHV-5) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Herpersvirus 5 (HHV-5) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Wakame Products

Wakame Products market is segmented by region (country), players, by Type and by Application. Pla ... Read More

Lab Shakers

Lab Shakers market is segmented by region (country), players, by Type and by Application. Players ... Read More

Fermentors

Fermentors market is segmented by region (country), players, by Type and by Application. Players, ... Read More